{"nctId":"NCT05718466","briefTitle":"Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy","startDateStruct":{"date":"2010-11"},"conditions":["Recurrent or Progressive Glioblastoma"],"count":35,"armGroups":[{"label":"Fractionated Radiosurgery and Bevacizumab","type":"EXPERIMENTAL","interventionNames":["Drug: Bevacizumab","Drug: Chemotherapy","Radiation: Fractionated radiosurgery"]},{"label":"Bev with Chemo","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Bevacizumab","Drug: Chemotherapy"]}],"interventions":[{"name":"Bevacizumab","otherNames":[]},{"name":"Chemotherapy","otherNames":["Either irinotecan or temozolomide or carboplatin or etoposide"]},{"name":"Fractionated radiosurgery","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Histologically proven intracranial glioblastoma multiforme with pathologic or imaging confirmation of tumor progression or regrowth after failure of two previous treatment regimens\n* Initial low-grade glioma and a subsequent diagnosis of glioblastoma or gliosarcoma\n* History and physical exam, including neurologic examination, within 4 weeks prior to registration\n\nExclusion Criteria:\n\nâ€¢ Warfarin or LMW heparin patients must have no active bleeding or pathological condition that carries a high risk of bleeding","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"100 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Local Tumor Control","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"PRIMARY","title":"Overall Survival","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.2","spread":null},{"groupId":"OG001","value":"4.8","spread":null}]}]}]},{"type":"PRIMARY","title":"Progression Free Survival","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.1","spread":null},{"groupId":"OG001","value":"1.8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":18},"commonTop":[]}}}